$OTLC·4

OXIGENE INC · Feb 6, 2:28 PM ET

OXIGENE INC 4

4 · OXIGENE INC · Filed Feb 6, 2007

Insider Transaction Report

Form 4
Period: 2007-01-25
CHAPLIN DAVID
Chief Scientific Officer
Transactions
  • Award

    Option to Purchase Common Stock

    2007-01-25+25,00025,000 total
    Exercise: $4.18From: 2008-01-25Exp: 2017-01-24Common Stock (25,000 underlying)
Footnotes (1)
  • [F1]The option shall vest in equal annual installments over four years beginning on the first anniversary of the grant.

Documents

1 file
  • 4
    rrd145069.xmlPrimary

    OPTION GRANT - DR. CHAPLIN